<DOC>
	<DOCNO>NCT02370524</DOCNO>
	<brief_summary>The primary objective exploratory image study characterize [ 18F ] T807 , investigational PET radioligand image Tau ( think downstream biomarker indicative neurodegeneration condition AD ) .</brief_summary>
	<brief_title>Quantitative Evaluation 18FT807 Potential PET Radioligand Imaging Tau Patients With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>For Subjects : Written inform consent assent obtain Female subjects/volunteers must either surgically sterile ( mean hysterectomy , bilateral oophorectomy , tubal ligation ) postmenopausal least 1 year , childbearing potential , must commit use two effective contraception method duration study . Male subjects/volunteers partner childbearing potential must commit use two effective method contraception , one barrier method male subject . Prodromal Mild Alzheimer 's Disease Subjects Males females age 50 90 year . Study partner notice recent gradual decrease subject 's memory ( e.g. , prior 12 month ) , subject may may aware . For prodromal subject , abnormal memory function screen 4 week prior screen base FCSRTIR : Free recall &lt; 17 , Total recall &lt; 40 , Free recall &lt; 20 total recall &lt; 42 . Individuals mild AD must meet criterion base National Institute Neurological Communicative Disorders Stroke/Alzheimer 's Disease Related Disorders Association Diagnostic Statistical Manual Mental Disorders , Version 5 , criterion . This evidence may compile screen must fully document subject 's study file baseline visit . Have MMSE ( Folstein et al . 1975 ) score screen &gt; 20 . Have Amyvid ( florbetapir F 18 injection ) scan screen demonstrates amyloid bind base qualitative analysis ( visual read ) meet criteria AD . Modified Hachinski Ischemia Scale ( Moroney et al . 1997 ) score â‰¤ 4 . A neuroimaging evaluation brain MRI support diagnosis AD evidence focal disease account dementia MRI exclusion criterion . Medications take symptomatic treatment AD must maintain stable dosage regimen least 4 week [ 18F ] T807 image visit . Able participate schedule evaluation . The subject appropriate caregiver community dwell caregiver capable accompany subject visit center judge investigator . In opinion investigator , subject caregiver compliant high probability complete study . Healthy Volunteers Males female age 20 90 year . Younger healthy control age 2049 old healthy control age 5090 . Healthy volunteer clinically relevant finding physical examination screen upon report [ 18F ] T807 image visit . No suspicion cognitive impairment/early dementia MMSE judge investigator ( MMSE &gt; 28 ) . No concomitant medication , overthecounter , supplement , agent intend improve cognition prevent cognitive decline A negative Amyvid ( florbetapir F 18 injection ) scan screen base qualitative analysis ( visual read ) . For All subject : Current prior history alcohol drug abuse . Severe systemic disease base history physical examination . Positive result urine screen illicit drug . Laboratory test clinically significant abnormality Clinically significant unstable medical psychiatric illness . Positive test hepatitis B C HIV . Prior participation research protocols clinical care last year radiation exposure &gt; 15 mSv participation study would require subject/volunteer exceed annual limit . Pregnancy breastfeed . Current prior history coagulopathy . The subject evidence clinically significant gastrointestinal , cardiovascular , hepatic , renal , hematological , neoplastic , endocrine , neurological , immunodeficiency , pulmonary , disorder disease . History significant drug and/or food allergy , anaphylactic/anaphylactoid reaction allergen . Contraindication arterial cannulation . Unsuitable vein repeat venipuncture . MRI exclusion criterion include : nonAD pathology infectious disease , spaceoccupying lesion , normal pressure hydrocephalus , abnormality associate significant CNS disease Any lacunar infarct strategically important location know lead cognitive impairment thalamus , hippocampus either hemisphere , head leave caudate Severe subcortical microvascular disease ( Fazekas score 3 deep white matter hyperintensities ) ( Fazekas et al . 1987 ) Territorial infarct macroscopic hemorrhage ( &gt; 10 mm ) Implants implanted cardiac pacemaker defibrillator , insulin pump , cochlear implant , metallic ocular foreign body , implanted neural stimulators , CNS aneurysm clip medical implant certify MRI , history claustrophobia MRI Observed claustrophobia screen Ferromagnetic foreign body , metal shrapnel bullet fragment , need consider individual basis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>